Its suitability for non-invasive high-contrast imaging of CXCR4 overexpressing cancers has been initially demonstrated for hematological malignancies 12, 15-18, but has also been successfully extended towards other tumor entities 19-27. The gene discussed is CXCR4; the disease is cancer.